Infinity Pharma Stock Price (NASDAQ:INFI)

Add to My Stocks
$1.92 $0.05 (2.54%) INFI stock closing price Apr 21, 2017 (Closing)
Prev Close* : $1.97
Market Cap:
$96.82M
Day Low: $1.88
52 Week Low: $0.84
Open: $1.95
Volume: 683425
Day High: $2.01
52 Week High: $6.63
Dividend:
N/A

Latest Stock Market News

Latest Articles

Infinity Pharma News - From Partners

Should You Get Rid of Patheon (PTHN) Now?   by Zacks on Mar 29, 2017

INFI Stockcharts

View INFI PE ratio, PS ratio stocks charts and compare with peers.
INFI Chart
Note: Compare Infinity Pharma stock price history with the index and industry peers.

Infinity Pharma Valuation

PS ratio (
price to sales ratio
)
5.14
PB ratio (
price to book ratio
)
1.04

Infinity Pharma Financial Ratios

Debt to Equity
0.24

INFI Industry Peers

Company Price Change (%)
Novan Inc (NOVN)5.410.04 (0.73%)
Merus Labs International (MSLI)0.770 (0%)
Abbvie (ABBV)63.820.04 (0.06%)
Tg Therapeutics (TGTX)10.30.15 (1.44%)
Celgene (CELG)122.261.01 (0.82%)
Seattle Genetics (SGEN)65.341.7 (2.54%)
Bristol-myers Squibb (BMY)53.480.04 (0.07%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Aratana Therapeutics (PETX)6.160.29 (4.94%)
Redhill Biopharma (RDHL)10.380.41 (4.11%)
Ionis Pharma (IONS)44.261.35 (3.15%)
Spectrum Pharma (SPPI)7.090.12 (1.72%)
PTC Therapeutics (PTCT)11.370.12 (1.07%)
Nutraceutical International (NUTR)29.90.2 (0.67%)
Arrowhead Pharma (ARWR)1.520.01 (0.66%)
Top gainers from Medical-Drugs industry
* As of Apr 22, 2017
CompanyPriceChange (%)
Corcept Therapeutics (CORT)9.110.88 (8.81%)
AcelRx Pharma (ACRX)2.550.15 (5.56%)
Rigel Pharma (RIGL)2.870.16 (5.28%)
Cumberland Pharma (CPIX)5.940.31 (4.96%)
Galectin Therapeutics (GALT)3.090.14 (4.33%)
Aralez Pharma (ARLZ)1.570.07 (4.27%)
Valeant Pharmaceuticals Intl Inc (VRX)8.510.37 (4.17%)
Top losers from Medical-Drugs industry
* As of Apr 22, 2017

Infinity Pharmaceuticals Inc. Stock News - Partner Headlines

Value Investing in BioPharma   on Nov 18, 2015

Infinity Pharma Financial Statements

income statement20162015201420132012
Net Sales Or Revenues18.72M109.06M164.99M-47.11M
Net Income-30.1M-128.37M-17.41M-126.78M-53.96M
Total Operating Expense49.62M236.16M172.91M127.67M99.92M
view Infinity Pharmaceuticals Inc. income statement
balance sheet20162015201420132012
Total Assets125.65M288.82M369.14M230.71M335.66M
Total Liabilities43.2M190.26M159.67M29.43M25.45M
Shareholders Equity82.45M98.55M209.47M201.27M310.2M
view Infinity Pharmaceuticals Inc. balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-29.22M26.97M109.57M-3.71M-39.39M
Net Cash From (Used By) Operating Activities-154.35M-83.65M117.71M-113.9M-80.13M
Increase (Decrease) In Prop Plant And Equipment1.47M-6.42M-1.36M-1.75M-1.3M
view Infinity Pharmaceuticals Inc. cashflow statement

Infinity Pharma Stock Message Board

Infinity Pharma stock lost -2.54 %, and the last close price as of 21 Apr, 2017 is 1.92 for INFI stock. The total market value as denoted by 99.34M for Infinity Pharma, is the market value of the company's outstanding shares. Infinity Pharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

Demand for a stock decides its stock market price. For example, if more investors want to buy INFI stock than sell it, then Infinity Pharma stock price goes up. Conversely, if more investors wanted to sell INFI stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume of shares traded stood at 683425 on the last trading day, as is evident from Infinity Pharma stock chart, and INFI stock quote data. A dividend is a cash payment from a company's earnings and is distributed among shareholders. Infinity Pharma does not pay dividends. One can observe stock price trends and check for volatility by checking Infinity Pharma stock price history.